| 000 | 01492 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515041637.0 | ||
| 264 | 0 | _c20061218 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1556-9527 | ||
| 024 | 7 |
_a10.1080/15569520600860355 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aModjtahedi, Bobeck S | |
| 245 | 0 | 0 |
_aGender: a possible determinant in dosing of dermatologic drugs--an overview. _h[electronic resource] |
| 260 |
_bCutaneous and ocular toxicology _c2006 |
||
| 300 |
_a195-210 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSaquinavir _xadministration & dosage |
| 650 | 0 | 4 | _aSex Characteristics |
| 700 | 1 | _aModjtahedi, Sara P | |
| 700 | 1 | _aMaibach, Howard I | |
| 773 | 0 |
_tCutaneous and ocular toxicology _gvol. 25 _gno. 3 _gp. 195-210 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15569520600860355 _zAvailable from publisher's website |
| 999 |
_c16559336 _d16559336 |
||